Bristol-Myers Squibb Company (VIE:BMYS)

Austria flag Austria · Delayed Price · Currency is EUR
40.35
-2.34 (-5.48%)
At close: Nov 14, 2025
-5.48%
Market Cap85.04B
Revenue (ttm)40.94B
Net Income (ttm)5.15B
Shares Outn/a
EPS (ttm)2.53
PE Ratio16.52
Forward PE7.66
Dividend2.22 (5.20%)
Ex-Dividend DateOct 3, 2025
Volume698
Average Volume54
Open41.43
Previous Close42.69
Day's Range39.81 - 41.71
52-Week Range36.69 - 58.44
Betan/a
RSI54.11
Earnings DateOct 30, 2025

About VIE:BMYS

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Vienna Stock Exchange
Ticker Symbol BMYS
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.